# Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections

> **NCT02620774** · PHASE1 · COMPLETED · sponsor: **Hartford Hospital** · enrollment: 16 (actual)

## Conditions studied

- Diabetes
- Wound Infection
- Healthy Volunteers

## Interventions

- **DRUG:** Ceftolozane/tazobactam
- **PROCEDURE:** Microdialysis Catheter Insertion

## Key facts

- **NCT ID:** NCT02620774
- **Lead sponsor:** Hartford Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-19
- **Primary completion:** 2017-04
- **Final completion:** 2017-04
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2019-01-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02620774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02620774, "Tissue Penetration of Ceftolozane/Tazobactam in Diabetic Patients With Lower Limb Infections". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02620774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*